The basic organization of the human vasoactive intestinal peptide\pituitary adenylate cyclase-activating peptide receptor (VPAC) 1 promoter was investigated after cloning the 5h-flanking region (1.4 kb) of the VPAC1 gene from a human genomic library. Subsequent functional analysis of various deletions of the 5h-flanking sequence, subcloned upstream of a luciferase reporter gene, was carried out in HT-29 cells. The minimal promoter region identified encompasses the k205\j76 sequence and contains a crucial CCAAT box (k182\k178) and a GCrich sequence. Moreover a region (k1348\k933) containing a silencer element was identified. We previously showed that the expression of the VPAC1 receptor binding site is strictly dependent upon the enterocytic differentiation of human colon cancer Caco-2 cells [Laburthe, Rousset, Rouyer-Fessard, Couvineau, Chantret, Chevalier and Zweibaum (1987) J. Biol. Chem. 262, [10180][10181][10182][10183][10184]. In the present study we show that
INTRODUCTION
The neuropeptide vasoactive intestinal peptide (VIP) is widely distributed in the central and peripheral nervous systems and has a large spectrum of biological actions [1] . VIP interacts with two different receptors now referred to as human vasoactive intestinal peptide\pituitary adenylate cyclase-activating peptide receptor (VPAC) 1 and VPAC2 [2] , because they display very similar affinity for VIP and another regulatory peptide, the pituitary adenylate cyclase-activating peptide (PACAP) [3] . VPAC receptors belong to the class II G-protein-coupled receptor (GPCR) family [4, 5] , which include receptors for a family of peptides structurally related to VIP, such as glucagon and secretin as well as peptides unrelated to VIP, such as parathyroid hormone (PTH) and calcitonin [4] . This subfamily has been recently extended to the putative epidermal growth factor modulecontaining mucin like-peptide hormone receptor (' EMR1 ') [6] , the leucocyte activation antigen CD97 [7] and the α-latrotoxin receptor [8] .
Structure-function relationship studies of human VPAC receptors have provided evidence that the N-terminal extraAbbreviations used : AU, arbitrary units ; CMV, cytomegalovirus ; DMEM, Dulbecco's modified Eagle's medium ; FCS, fetal calf serum ; GPCR, G-protein-coupled receptor ; GRE, glucocorticoid response element ; RT-PCR, reverse transcriptase-PCR ; PACAP, pituitary adenylate cyclase-activating peptide ; PTH, parathyroid hormone ; PTHrP, PTH-related peptide ; VIP, vasoactive intestinal peptide ; VPAC, vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor ; VIPR-RP, VPAC1 receptor repressor. 1 To whom correspondence should be addressed (e-mail coucou!bichat.inserm.fr). 2 Present address : Escuela Universitaria de Fisioterapia, Area de Bioquimica y Biologia Molecular, c/ Nicola' s Rabal, 17, 42003 Soria, Spain. The nucleotide sequence data reported here have been submitted to the GenBank2, EMBL, DDBJ and GSDB Nucleotide Sequence Databases under the accession number AJ012074.
transcriptase-PCR. A single transcript species of 3 kb is detected in differentiated cells by Northern-blot analysis. Accumulation of VPAC1 receptor mRNA is due to a 5-fold increase of transcription rate (run-on assay) without a change in mRNA half-life (9 h). Stable transfections of various constructs in Caco2Cl.20 cells and subsequent analysis of reporter gene expression, during the enterocytic differentiation process over 25 days of culture, further indicated that the k254\j76 5h-flanking sequence is endowed with the regulatory element(s) necessary for transcriptional regulation of VPAC1 during differentiation. Altogether, these observations provide the first characterization of the basic organization of the human VPAC1 gene promoter and unravel the crucial role of a short promoter sequence in the strict transcriptional control of VPAC1 expression during differentiation of human colon cancer Caco-2 cells.
Key words : epithelium, intestine, PACAP, VIP. cellular domain is crucial for VIP binding and correct delivery of the receptor to the plasma membrane [9] [10] [11] . Other functional domains for VIP binding [12, 13] and peptide selectivity [14] have also been identified in extracellular loops and the third transmembrane segment of the human VPAC1 receptor. Finally, constitutively active mutants of the human VPAC1 receptor have been generated by point mutations at junctions of the second [15] and fourth [16] transmembrane segments with intracellular loops. While the functional roles of several domains of the VPAC1 receptor protein are now documented, very little is known about the VPAC1 receptor gene and its regulation. It is known that the human VPAC1 receptor gene has a complex organization with many introns [17] , like genes encoding all class II GPCRs [4] . The human VPAC1 receptor gene spans 22 kb and is composed of 13 exons [17] . Although the 5h-flanking region of the human VPAC1 receptor gene has been sequenced [17] , no functional studies are currently available regarding the basic properties of the receptor promoter.
It has been known for many years that differentiation of intestinal epithelial cells is associated with significant changes in expression of cell surface receptors [18] [19] [20] [21] [22] [23] , including VIP receptors [24, 25] . Moreover, intestinal epithelial cells represent a physiologically relevant target of VIP since the neuropeptide promotes water and electrolyte secretion and mucus output, and also exerts control over metabolism and proliferation in intestinal epithelium [4, 26] . We have shown previously that expression of VPAC1 receptors is strictly dependent upon enterocytic differentiation of human colon cancer Caco-2 cells [25] . Differentiated cells express a high amount of VPAC1 receptors whereas undifferentiated cells show a very low density of receptors [25] . The accumulation of VPAC1 receptors during Caco-2 cell differentiation represents the crucial event in the development of the adenylate cyclase response to VIP [25] . The Caco-2 cell model represents an invaluable cellular model [26] for the study of the regulation of human VPAC1 receptor expression inasmuch as it is reminiscent of the situation found in normal human small intestine where mature villus cells express more VPAC1 receptors [intestinal epithelial cells and colon cancer express the VPAC1 but not the VPAC2 receptor subtype (J-J. Maoret, unpublished work)] than proliferative and undifferentiated crypt cells [24] .
In this context, the present study has a 2-fold objective (1) to analyse the basic organization of the human VPAC1 receptor gene promoter and (2) to investigate the mechanism whereby VPAC1 receptors accumulate upon enterocytic differentiation of Caco-2 cells. We provide evidence for regulation of mRNA level by strict transcriptional control, and we have characterized the crucial role of the human VPAC1 promoter in this regulation.
MATERIALS AND METHODS

Materials
All chemicals and reagents were purchased from Sigma (St Louis, MO, U.S.A.), Bioprobe (Paris, France), Interchim (Asnie' res, France), Gibco-BRL (Cergy-Pontoise, France) or Promega (Madison, WI, U.S.A.) unless otherwise indicated. Radioactive isotopes ("#&I, $#P and $&S) were purchased from Amersham (Les Ullis, France). Native VIP was purchased from Neosystem (Strasbourg, France). "#&I-VIP was labelled as previously described [11] .
Cell culture
The Caco-2Cl.20 cell clone was obtained by cloning of parental Caco-2 cells (A.T.C.C. no. HTB-37 ; passage 20) using the limiting dilution method. Briefly, a monodispersed cell suspension was distributed to microtest plates at a mean ratio of 0.9 cells\well. Among several clones obtained clone 20, referred to as Caco-2Cl.20, was used in further studies. Cultured cell lines HT-29 (A.T.C.C. no. HTB-38 ; passages 165-172) and Caco-2Cl.20 (passages 6-15) were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 % (v\v) fetal calf serum (FCS) for HT-29 cells and 20 % FCS\1 % (v\v) non-essential amino acids for Caco-2Cl.20 cells.
Immunofluorescence studies, measurement of enzyme activities and cell layer resistivity
Indirect immunofluorescence using monoclonal anti-(dipeptidyl peptidase IV) antibody or polyclonal anti-(sucrase isomaltase) antibody [27] was performed on cells grown on glass coverslips according to a previously published technique [15] . Optical sections through Caco-2Cl.20 cells were performed in the plane perpendicular (xz plane) to the cell monolayer using a Leica TCS 4D confocal fluorescence microscope. After preparation of cell homogenates [25] , sucrase isomaltase (EC 3.2.1.48) and dipeptidyl peptidase IV (EC 3.4.14.5) activities were determined as described in [27] . Cell-layer resistivity was measured using a Millicell-ERS resistivimeter (Millipore, Bedford, MA, U.S.A.) on cells grown on Tranwell clear membrane (Corning, Brumath, France).
Ligand binding assay
Cell homogenates and ligand binding assays were prepared as previously described [15] . Specific binding was calculated as the difference between the amount of "#&I-VIP bound in the absence and in the presence of 1 µM unlabelled VIP. Protein was determined using the Bio-Rad protein assay (Bio-Rad, Hercules, CA, U.S.A.).
Detection of mRNA : RNase protection assay, Northern-blot analysis and reverse transcriptase (RT)-PCR
For the RNase protection assay, cDNA encoding the human VPAC1 receptor, subcloned into a pcDNA I vector, was linearized by NheI before transcription. A human β-actin cDNA subcloned into a pcDNA I vector (Invitrogen, Leek, The Netherlands) served as a template for an antisense probe of human β-actin mRNA. Templates were transcribed with Sp6 RNA polymerase, yielding antisense probes of 414 bases for the human VPAC1 receptor and 156 bases for human β-actin. The protected fragments were 354 bases and 123 bases, respectively. The RNase protection assay was performed as described in [28] .
RT-PCR experiments and Northern-blot analysis for the VPAC1 receptor were performed exactly as described in [29] . Amplification of mRNA encoding the G s α subunit was performed as previously described [29] using 5h-GCAATTATTACTGTT-TCGGTTGGCT-3h as the sense oligonucleotide and 5h-GCG-TTCTTTACGAACAGCCAAGCC-3h as the antisense oligonucleotide.
Measurement of RNA stability and run-on assays
RNA stability was determined by incubating Caco-2Cl.20 cells at 37 mC for various periods in the presence of actinomycin D (10 µg\ml). Total RNA was then extracted as described above and quantified using the RNase protection assay. Results were expressed as % of control (time 0 of incubation with actinomycin D) and the VPAC1 receptor half-life was determined when 50 % of VPAC1 receptor mRNA was detectable.
Isolation of nuclei and run-on assays were performed exactly as described in [30] . Blots were autoradiographed and quantified using the NIH image 1.62 software. Results were expressed as follows :
where AU VPAC" receptor , AU β -actin and AU pcDNA I represent the absorbance in arbitrary units (AU), corresponding to hybridization of the labelled RNA with the VPAC1 receptor probe, the β-actin probe and the pcDNA I vector, respectively.
Promoter cloning and plasmid constructions
A total of 4i10& clones of a human placental genomic library in a pWE15 cosmid vector (Stratagene, La Jolla, CA, U.S.A.) were screened, under standard conditions of plaque hybridization [29] , with a $#P-labelled cDNA probe encoding the human VPAC1 receptor N-terminal region (bases 1-440). One positive clone ($ 10 kb size) was selected. The reporter gene eucaryotic expression vector pSNeoLuc was constructed from VPAC1 receptor promoter and cell differentiation the pcDNA3 (Invitrogen) vector by excision of the cytomegalovirus (CMV) promoter (pSNeo vector) and addition of the firefly luciferase reporter gene. The BamHI-SstII fragment of the 5h-flanking region of the VPAC1 receptor was fused immediately 5h to the firefly luciferase reporter gene into a pSNeoLuc vector. It was fully sequenced by the dideoxy-chain-termination method using an automatic sequencer (Genome Express, Grenoble, France). The resulting p1424Luc clone corresponding to the sequence k1348\j76 of the human VPAC1 receptor gene was used to perform 5h deletion constructions. The resulting plasmids were named according to the size of their respective VPAC1 receptor promoter fragments as follows : p1008Luc was obtained by digestion of p1424Luc with BstXI, blunt-ended and religation ; p822Luc was obtained by digestion with exonuclease III using the Exo mung bean deletion kit (Stratagene) ; p330Luc was constructed by digestion of p1424Luc with BamHI-XhoI, blunt-ended and religation ; p224∆330Luc was constructed by digestion of p1424Luc with XhoI and religation ; p295Luc was constructed by digestion of p330Luc with StuI, blunt-ended, digested with XbaI and inserted into a pSNeo vector ; p330∆130Luc was constructed by digestion of p330Luc with SmaI-KpnI and inserted into a pSNeoLuc vector ; p281Luc, p249Luc, pX1T, pX1C1 and pX1C2 were obtained by site-directed mutagenesis as described in [9] ; p130Luc was obtained by digestion of p1424Luc with SmaI-XbaI and inserted into the pSNeo vector. Construction of p4100Luc was carried out by selecting another positive clone with a larger size (10 kb). All constructions were verified by direct sequencing.
Cell transfection and luciferase activity measurement
Cells (HT-29 or Caco-2Cl.20) were transfected with 15 µg of pSNeoLuc or 15 µg of promoter-luciferase gene construct and 1 µg of pRL, containing cDNA coding Renilla luciferase, using the calcium phosphate\DNA co-precipitation method following PROFECTION kit instructions (Promega). For Caco-2Cl.20 cells which had to be followed over 25 days during the enterocytic differentiation process, stable transfections were performed by addition of 1 g\l G418 (Gibco-BRL) to the culture medium. After selection, resistant cells were grown in DMEM supplemented with 20 % FCS and 1 % non-essential amino acids for up to 5 days (undifferentiated cells) or 20-25 days (differentiated cells). Luciferase activities (firefly luciferase and Renilla luciferase) were measured in cell extracts using a dual-luciferase reporter assay system kit (Promega). Renilla luciferase activity in these same extracts was measured to correct for variations in transfection efficiency. Relative luciferase activity of various promoter constructions was calculated as the ratio between firefly luciferase and Renilla luciferase activities for each transfection and then reported as % of the ratio determined for the p1424Luc construction. Background luciferase activity was determined with the promoterless vector, pSNeoLuc.
Electrophoretic mobility-shift assays
Cell nuclear extracts were prepared using the method described by Dignam et al. [31] . Synthetic oligonucleotides used for electrophoretic mobility-shift assays corresponded to CCAAT box 1 and 2 sequences. These sequences and those of competitor oligonucleotides used are shown in Table 1 . Doublestranded oligonucleotides were $#P-labelled using T4 kinase in the presence of [γ-$#P]ATP and purified from unincorporated radioactivity by passage through spin-columns (Pharmacia Biotech, Orsay, France). Samples containing 30 000 c.p.m. of 5h-end labelled double-stranded oligonucleotides were in- cubated for 30 min on ice with 5 µg of various nuclear extracts and 2 µg of poly(dI-dC) in binding buffer [20 mM Hepes buffer\ 50 mM NaCl\5 mM MgCl # \1 mM dithiothreithol\20 % (w\v) glycerol\0.1 mM PMSF\2 mM levamisole\0.1 µg\ml aprotinin\0.1 µg\ml bestatin\5 mM benzamidine, pH 7.9]. For competition experiments, a 100-fold molar excess of unlabelled double-stranded oligonucleotides was preincubated with nuclear extracts for 15 min on ice and then $#P-labelled probe was added for an additional 30 min incubation. All samples were electrophoresed on 6 % non-denaturating TBE (45 mM Tris\borate\ 1 mM EDTA) acrylamide gels for 2 h at 150 V. Gels were dried and autoradiographed overnight at k80 mC with an intensifying screen.
RESULTS
Cloning of the VPAC1 receptor promoter
In order to determine the basic properties of the VPAC1 receptor promoter, the 5h-flanking region of the VPAC1 receptor gene was cloned. A total of 4i10& clones of a human placental genomic library were screened with a $#P-labelled cDNA probe, coding for the N-terminal region (bases 1-440) of the receptor. Six positive clones were further characterized by restriction mapping and Southern-blot analysis using a $#P-oligonucleotide probe corresponding to bases 1-63 of the VPAC1 receptor. A fragment of a clone referred to as L1 and representing 1.5 kb upstream of the initiation codon was characterized and fully sequenced ( Figure 1 ). Consensus TATA box, CCAAT boxes and Sp1 sites, as well as other putative regulatory sequences, were identified and are indicated together with the ATG codon in Figure 1 .
Functional characterization of the minimal VPAC1 receptor promoter
To determine whether this cloned sequence had promoter activity, a 1424 bp fragment from nucleotide k1348 to j76 (Figure 1 ) was subcloned upstream of a luciferase reporter gene (p1424Luc). The purified DNA was transfected into human colon cancer HT-29 cells, which express endogenous VPAC1 receptor independently of the time of cell culture and allow reporter gene studies to be undertaken in transiently transfected cells [32] . As shown in Figure 2 , the 5h-flanking region of the VPAC1 receptor gene directed a high level of luciferase expression. This activity was about 33-fold higher than the background level determined by transfection of the pSNeoLuc promoterless plasmid (Figure 2 ). It should be noted that a luciferase construct containing the first 4.1 kb of the VPAC1 sequence upstream of the initiation codon (p4100Luc) exhibited the same level of promoter activity as the p1424Luc construct (Figure 2 ), supporting the idea that upstream sequences did not contain further functional regulatory element(s), at least when transfected into HT-29 cells.
The sequence borders of VPAC1 promoter activity were determined by using a set of progressively shorter 5h deletions of
Figure 1 Nucleotide sequence of the 5h-flanking region of the VPAC1 receptor gene
Putative binding sites for transcription factors are underlined in bold, the sequence of exon 1 started at j1 is underlined, the transcription start site (k15) identified by Sreedharan et al. [17] is indicated by the arrow and the translation initiation codon in exon 1 is boxed. 
Figure 3 Schematic representation of the VPAC1 receptor promoter
Hatched boxes indicate regions involved in the transcription of the VPAC1 receptor gene (silencer region, CCAAT box sequence and GC-rich region). Open and black boxes represent non-coding and coding regions of the first exon of the VPAC1 receptor gene, respectively. The start of exon 1 was set at j1. ATG and the arrow indicate the translation and transcription start sites, respectively. the p1424Luc construct. Deletions of the sequences k1348\ k933 (p1008Luc vector), k1348\k747 (p822Luc vector), k1348\k255 (p330Luc vector) and k1348\k220 (p295Luc vector) resulted in luciferase activities (approx. 50-fold higher than the background level) which were significantly higher than that observed with the k1348\j76 sequence (p1424Luc vector) ( Figure 2 ). These data supported the theory that the sequence k1348\k933 is endowed with a silencer element. Construction of a vector in which the upstream sequence k1348\k1124 was linked to the k255\j76 sequence (p224∆330Luc construct) confirmed this view. Indeed, luciferase activity was identical to that observed with the p1424Luc vector but significantly lower than that observed with the p330Luc vector (Figure 2 ), indicating the presence of silencer element(s) in the k1348\k1124 sequence. Further shorter deletions in the p1424Luc construct were analysed in the context of the presence of some putative regulatory elements such as a TATA box (k216\k211), two CCAAT boxes (k182\k178 and k107\k103) and a GC-rich region (k68\k38). Deletion of the sequence k1348\k206 (p281Luc vector) resulted in a luciferase activity identical to that obtained for the p330Luc vector (Figure 2 ), supporting the idea that the TATA box is not important for promoter activity. This was confirmed by the fact that mutating this TATA sequence into ATTT in the p330Luc vector did not result in any change in luciferase activity (results not shown). A further deletion between k1348 and k174 (p249Luc vector) resulted in a dramatic decrease in luciferase activity (Figure 2) , indicating that the minimal promoter region encompasses the k205\j76 sequence. These data also suggested that the CCAAT box sequence k182\ k178 is crucial for promoter activity. This was confirmed by the fact that mutating this CCAAT sequence into GGAAT in the p330Luc vector resulted in an almost complete absence of luciferase activity (results not shown). In this context, we also mutated the other CCAAT box (k107\k103) into GGAAT in the p330Luc vector. This mutation did not change the promoter activity (results not shown), supporting the theory that this second CCAAT box is not functional in the receptor promoter, a conclusion which is in good agreement with electrophoretic mobility-shift experiments (see below). Finally, partial deletion of the GC-rich region by deleting the sequence k54\j76 in the p330Luc vector (corresponding to the p330∆130Luc vector in Figure 2 ) which contains the crucial CCAAT box (see above) abolished luciferase activity, supporting the idea that the GCrich region is instrumental in promoter activity. Taken together these data showed that a minimal 281 bp sequence containing a crucial CCATT box and a GC-rich sequence upstream of the initiation site of the human VPAC1 receptor is required for promoter activity (Figure 3 ). They also indicated the presence of silencer element(s) between positions k1348 and k1124 upsteam of this minimal promoter (Figure 3 ). VPAC1 receptor promoter and cell differentiation
Figure 4 Gel-retardation experiments using CCAAT-box oligonucleotides and protein extract from HT-29 cells
Electrophoretic mobility-shift assays were performed using nuclear extract (NE) from HT-29 cells (5 µg of protein) incubated with labelled double-stranded wtC1 oligo (A and B, see Table  1 ) or wtC2 oligo (C, see Table 1 ) in the presence of 2 µg of poly(dI-dC) as described in the Materials and methods section. Binding specificity was established using increasing amounts (10, 25, 50 and 100 times molar excess) of unlabelled competitor oligonucleotide representing CCAAT box 1 (wtC1) (A, see Table 1 ), muC1 (B, see Table 1 ) and CCAAT box 2 (wtC2) (C, see Table 1 ). The incubation media were electrophoresed on a 6 % polyacrylamide nondenaturating gel and bands were visualized by autoradiography. Specific complexes are indicated by arrows. Controls without nuclear extract are shown (kNE).
Band-shift analysis of CCAAT box sequences
In order to confirm the functional property of the CCAAT box sequence (k182\k178), an electrophoretic mobility-shift experiment was carried out using sequences between k191 and k91 as probes and HT-29 cell nuclear extracts. As shown in Figure 4 (A), three major complexes appeared on the gel when a $#P-oligonucleotide corresponding to sequence k191\k166 (Table 1) was used. The labelling of these three bands could be competitively prevented by preincubation with increasing concentrations of unlabelled oligonucleotide probe, indicating that interactions occurred between nuclear proteins and this promoter region. When the same experiment ( Figure 4B ) was carried out in the presence of increasing concentrations of unlabelled oligonucleotide mutated at the CCAAT locus (sequence k191\k166, Table 1 ) the labelling of the three bands was not prevented, demonstrating that nuclear proteins specifically bind to the CCAAT box sequence (k182\k178). In contrast, when a $#P-oligonucleotide corresponding to sequence k116\k91 containing the second CCAAT box sequence (k107\k103, Figure  1 ) was incubated in the presence of HT-29 cell nuclear extracts, no specific band was detected ( Figure 4C ), further indicating that this CCAAT box is inactive in the VPAC1 receptor promoter.
Differentiation-dependent regulation of VPAC1 receptor mRNA levels in Caco-2 cells
The human colon adenocarcinoma cell line Caco-2 in culture spontaneously differentiates into enterocytes which exhibit apical brush borders, tight junctions and express brush border hydrolases [26, 32] . Table 2 shows some characteristics of differentiation of the Caco-2 cell clone used in this study, which is referred to as Caco-2Cl. 20 . At day 25 of culture, Caco-2Cl.20 cells, grown on Tranwell clear membrane, exhibited high cell-layer resistivity indicating the establishment of tight junctions between polarized epithelial cells. Moreover, the activities of sucrase isomaltase and dipeptidyl peptidase IV, two enzyme markers of intestinal differentiation [33] , increased markedly from day 5 of culture to day 25 of culture. Immunofluorescence detection of sucrase isomaltase and dipeptidyl peptidase IV at day 25 of culture showed expression of both enzymes at the cell surface ( Figure 5 ). For both enzymes, no immunofluorescence staining could be ) or β-actin cRNA for 12 h at 55 mC. After digestion and extraction, protected fragments were resolved on a 6 % denaturated polyacrylamide gel. Controls were performed using labelled sense probe or tRNA instead of cRNA in the hybridization reactions (no labelled bands were detected). (Middle panel) 50 µg of total RNA were applied to each lane. The blot was hybridized at high stringency with 32 P-labelled VPAC1 receptor cDNA. (Bottom panel) Total RNA (10 µg) was reverse-transcribed and resulting cDNAs were used as templates for PCR reactions as described in [30] . After electrophoresis and transfer, the blot was hybridized with a 32 P-labelled VPAC1 receptor probe or a 32 P-labelled G s α subunit probe.
observed at day 5 of culture (results not shown). Laser-scanning confocal microscopy of sections optically generated in a plane perpendicular to that of the polarized cell monolayer at day 25 of culture showed exclusive expression of both sucrase isomaltase and dipeptidyl peptidase IV at the apical membrane of polarized cells ( Figure 5 ). Altogether, these observations indicate that Caco-2Cl.20 cells undergo typical enterocytic differentiation.
In a previous report we have demonstrated that in Caco-2 cells the expression of the VPAC1 receptor is strictly dependent upon enterocytic differentiation [25] . Scatchard analysis of competitive inhibition of "#&I-VIP binding to Caco-2Cl.20 cell membranes by unlabelled VIP (results not shown) revealed a single class of VPAC1 receptor, the concentration of which increased markedly from undifferentiated cells at day 5 of culture to differentiated cells at day 25 of culture (Table 2 ). In order to determine the amount of VPAC1 receptor mRNA in differentiated and undifferentiated cells, RNase protection assays were performed. Figure 6 shows the results of a representative experiment. A protected fragment of appropriate size (354 bp) was detected. At VPAC1 receptor promoter and cell differentiation day 5 of culture (undifferentiated cells) a low level of VPAC1 receptor mRNA was detected ( Figure 6 ). In contrast, at day 25 of culture (differentiated cells) a high amount of VPAC1 receptor mRNA was detected ( Figure 6 ). Specificity of mRNA detection was determined in the presence of a sense probe or tRNA and no protected fragment was observed (results not shown). The use of human β-actin as a control probe showed that a protected fragment of appropriate size (123 bp) was detected at a similar level in differentiated and undifferentiated Caco-2Cl.20 cells (Figure 6 ). Very similar results were obtained by RT-PCR experiments using specific VPAC1 receptor primers, since a low amount of amplified DNA was observed when cells were undifferentiated but a high level when cells were differentiated ( Figure 6 ). This contrasted with the data obtained using primers of the G s α subunit. Indeed, identical amounts of amplified DNA were observed regardless of the state of cell differentiation ( Figure 6 ). Finally, Northern-blot analysis of VPAC1 receptor mRNA indicated the presence of a single transcript species of approx. 3 kb in differentiated cells (Figure 6 ). No receptor mRNA could be detected in undifferentiated cells by this technique, probably due to a lack of sensitivity ( Figure 6 ). These results strongly suggested that the dramatic increase of VPAC1 receptor expression during enterocytic differentiation of Caco2Cl.20 cells is regulated at the mRNA level.
Stability and transcription rate studies of the VPAC1 receptor mRNA
The increase of VPAC1 receptor mRNA during differentiation of Caco-2Cl.20 cells could be due to a modification of the stability of transcripts and\or to a change in the transcription rate of the VPAC1 receptor gene. To investigate the two mechanisms, transcript stability and run-on transcription assays were performed. The half-life of the VPAC1 receptor mRNA was determined after inhibition of mRNA transcription with actinomycin D in Caco-2Cl.20 cells at day 5 and day 25 of culture. The disappearance of VPAC1 receptor mRNA with time was then measured by RNase protection assays (Figure 7) . The stability of VPAC1 receptor mRNA was very similar in undifferentiated (day 5) and differentiated (day 25) cells with half-lives of 9.0p0.8 h and 9.2p0.5 h, respectively. The run-on assay indicated that the rate of receptor gene transcription was 5-fold higher in nuclei from differentiated cells than in nuclei from undifferentiated cells (Figure 7) . Taken together these data indicated that the expression of the VPAC1 receptor during enterocytic differentiation of Caco-2Cl.20 cells is transcriptionally regulated.
Role of the promoter in the transcriptional regulation of the expression of the VPAC1 receptor in Caco-2Cl.20 cells
In order to determine the regulatory sequence(s) of the VPAC1 receptor promoter involved in this transcriptional regulation, the p1424Luc vector (see Figure 2) containing the k1348\j76 sequence was stably transfected into Caco-2Cl.20 cells, and luciferase activity was measured during the enterocytic differentiation process in culture. Stable transfections were necessary since differentiation took place over 25 days of culture. As shown in Figure 8 , a very low luciferase activity was measured in undifferentiated cells (day 5 and day 7 of culture). When cells reached confluency, they started differentiating into enterocytes (from day 10 of culture and onward) and luciferase activity increased markedly to reach a maximum at day 20 of culture when cells were fully differentiated (Figure 8 ). The increase in luciferase activity during Caco-2Cl.20 cell culture correlated well with the increase in specific "#&I-VIP binding ( Figure 8B ). Notably the ratios of activities in differentiated cells (day 25) and undifferentiated cells (day 5) were identical for luciferase activity in Caco-2Cl.20 cell homogenates and "#&I-VIP binding to Caco2Cl.20 cell membranes, i.e. approx. 8-9 (Figure 8) . These results strongly suggested that the k1348\j76 5h-flanking sequence contains regulatory sequence(s) involved in the transcriptional control of the VPAC1 receptor during differentiation of Caco2Cl.20 cells.
In order to identify the region(s) of the promoter responsible for this transcriptional control, a set of 5h deletions of the p1424Luc construct were stably transfected into Caco-2Cl.20 cells and luciferase activity was measured at day 5 and day 20 of culture ( Figure 9) . Deletion of the k1348\k254 sequence did not modify the pattern of expression of luciferase activity during differentiation of Caco-2Cl.20 cells (Figure 9 ). Indeed, transfection of p1008Luc, p822Luc and p330Luc vectors resulted in low luciferase activity at day 5 of culture and high activity at day 20 of culture. In contrast, a control construction containing the CMV promoter upstream of the luciferase reporter gene resulted in high luciferase activities in both undifferentiated and differentiated Caco-2Cl.20 cells (Figure 9 ). Furthermore, it is worth pointing out that when the p1008Luc, p822Luc or p330Luc vectors were transfected into Cos-7 cells, Hela cells or HT-29 cells, luciferase activities were independent of the culture conditions, i.e. exponential growth phase or at cell confluency (results not shown). These results strongly suggested that the k254\j76 5h-flanking sequence contains the regulatory element(s) necessary for the transcriptional regulation of the expression of VPAC1 receptors during differentiation of Caco2Cl.20 cells. They also indicated that the silencer region k1348\k1124 is not involved in the differentiation-dependent transcriptional control of the receptor.
DISCUSSION
In this study, we have delineated the basic organization of the human VPAC1 receptor gene promoter, and characterized its crucial role in transcriptional control of the receptor during differentiation of colon cancer Caco-2Cl.20 cells. Functional assays using various 5h-flanking sequences of the VPAC1 receptor promoter linked to a luciferase reporter gene showed that the minimal sequence having the maximal promoter activity is contained in the k254\j76 promoter region. Further analysis of this sequence revealed a housekeeping gene structure characterized by the absence of an active TATA box sequence but having two crucial elements for transactivation of the VPAC1 receptor gene, i.e. a CCAAT box (k182\k178) and a GC-rich region (k68\k38). There was also evidence for the existence of an upstream (k1348\k1124) silencer sequence. Finally, this study demonstrated that the expression of the VPAC1 receptor during enterocytic differentiation of the colon cancer cell clone Caco-2Cl.20 is under strict transcriptional control.
The 5h-flanking region of the human VPAC1 receptor gene contains many putative regulatory elements (see Figure 1) . Its promoter activity was assessed after insertion upstream of the luciferase coding sequence in the pSNeoLuc vector and detection in the human colon cancer cell line HT-29, which expresses receptors regardless of the cell culture conditions [32] . Deletion studies allowed us to define the minimal promoter sequence (k254\j76), which has a housekeeping gene structure with the absence of a functional TATA box. Only a CCAAT box and a GC-rich sequence appeared to be mandatory for promoter activity (see Figure 3 ). This contrasts with the rat VPAC1 receptor promoter which does not contain a functional CCAAT box [34] even though it is devoid of a TATA box sequence like the human promoter. Another important difference between the human and rat VPAC1 receptor promoters is that the rat promoter contains a negative glucocorticoid response element (GRE) between k21 and k36 relative to the transcription start site [35] . This GRE, that may act to regulate both basal and glucocorticoid-mediated expression of the rat VPAC1 receptor gene, is not present in the human VPAC1 receptor promoter (see Figure 1) . A hallmark of class II GPCRs, including the human VPAC1 receptor [17] , is a complex genomic organization with at least 12 exons and intron\exon boundaries generally well conserved (see [4] for reviews). It is therefore of interest to analyse the available information regarding promoters of class II GPCRs such as the mouse PTH\parathyroid hormone-related peptide (PTHrP) receptor [36] , the mouse PACAP receptor [37] , the mouse glucagon receptor [38] , the human glucagon-like peptide-1 receptor [39] and the human growth hormone releasing factor receptor [40] . All promoters lack an apparent TATA box and are devoid of CCAAT boxes with the exception of the PACAP receptor promoter [37] . GC-rich sequences have been identified in the proximal promoter region of the mouse PACAP receptor [37] and PTH\PTHrP receptor [36] . Altogether, our results and others [36] [37] [38] [39] [40] support the idea that promoters of class II GPCRs are TATA-less, a property found primarily in housekeeping genes. This characteristic is not specific for class II receptors since TATA-less promoters are also found in many class I GPCRs, such as adrenergic receptors [41] .
Construction of vectors in which progressively shorter 5h deletions of the 1.5 kb 5h-flanking region of the human VPAC1 receptor gene were cloned upstream of a luciferase reporter gene also indicated the presence of silencer element(s) in the k1348\ k1124 sequence (see Figure 2 ). This was confirmed by constructing a vector in which the upstream sequence k1348\k1124 was linked directly to the minimal promoter sequence k255\ j76. The existence of a transcriptional repressor sequence has also been reported in the rat VPAC1 receptor gene 5h region [34] . Recently, a novel transcriptional repressor protein known as VPAC1 receptor repressor (VIPR-RP) of the rat VPAC1 receptor gene was cloned and this repressor was shown to interect with a 42-bp element in the 5h-flanking region of the rat VPAC1 receptor gene [42] . Sequence analysis of the upstream k1342\k1124 sequence of the human VPAC1 receptor gene revealed no similarity with the rat 42-bp repressor element suggesting the existence of a specific human VIPR-RP and\or different specificity of VIPR-RP in human and rat.
Previous studies have shown that human colon cancer Caco-2 cells spontaneously differentiate in culture into mature enterocyte-like cells [26, 33] . This differentiation is a growthrelated process starting after confluency and is characterized by the presence of tight junctions, apical brush-border microvilli with associated hydrolases, formation of domes and epithelial electric properties unique to transporting epithelia (reviewed in [26] ). In particular, confluent Caco-2 cells catalyse active vectorial secretion of fluid and electrolytes across the cell monolayer, a process stimulated by VIP [43] . We recognized early on that Caco-2 cells were equipped with VIP receptors [44] and subsequently demonstrated that the expression of VIP binding sites and VIP-sensitive adenylate cyclase was strictly dependent upon differentiation of Caco-2 cells at cell confluency [25] . This Caco-2 cell model is invaluable insofar as it is a unique example of almost all-or-nothing expression of VIP receptors in a biological system [25, 44] , i.e. the VPAC1 receptor is the sole VIP receptor subtype expressed in intestinal epithelium (J.-J. Maoret, unpublished work). In the present work, we demonstrated that expression of VPAC1 receptors upon differentiation of a Caco-2 cell clone is under strict transcriptional control. Several lines of evidence support this view. (1) Depending on the technique used, VPAC1 mRNAs are either not (Northern-blot) or barely (RNase protection assay or RT-PCR) detectable in undifferentiated VPAC1 receptor promoter and cell differentiation Caco-2Cl.20 cells. In contrast, when cells are differentiated a high amount of VPAC1 receptor mRNA was detected regardless of the technique used (see Figure 6) . (2) The stability of receptor transcripts is identical in undifferentiated and differentiated cells with a half-life of approx. 9 h (see Figure 7) . (3) The transcription rate of the receptor gene is markedly increased in nuclei of differentiated cells as compared to undifferentiated cells, as assessed by run-on assays (see Figure 7) . (4) The p1424Luc vector consisting of the 1.5 kb 5h-flanking region of the human VPAC1 receptor gene cloned upstream of a luciferase reporter gene was stably transfected into Caco-2Cl.20 cells. Measurement of the reporter gene activity during cell differentiation revealed a very low activity in undifferentiated cells and a high activity in differentiated cells, an increase which correlated remarkably well with the increase in specific VIP binding (see Figure 8) . Deletions of the p1424Luc construct followed by stable transfection into Caco-2Cl.20 cells indicated that the k254\j56 genomic 5h-flanking sequence contains the regulatory elements sufficient to recapitulate the expression pattern of VPAC1 receptors during Caco-2Cl.20 cell differentiation.
Differentiation of small intestinal epithelial cells [45] or human colon cancer cell lines such as Caco-2 [26] is associated with gene expression of various proteins, which are regulated at the level of mRNA abundance. The level of mRNA of the enzyme dipeptidyl peptidase IV in Caco-2 cells [27] is not controlled at the transcriptional level but by an increased stability of mRNA in differentiated cells (D. Darmoul, personal communication). In contrast, most other proteins are regulated at the trancriptional level during the differentiation of Caco-2 cells as shown above for the VPAC1 receptor and described for sucrase isomaltase [27] , villin [46] , H-ferritin [47] , carcinoembryonic antigen [48] and apolipoprotein B [49] . The regulatory elements responsible for transcriptional control of gene expression upon terminal differentiation of Caco-2 cells have been described in some genes. A critical factor in regulating the sucrase-isomaltase promoter is Cdx2, an intestine-specific homeobox gene related to caudal [45] . Similarly, members of the caudal family of homeodomain proteins repress transcription of the apolipoprotein B promoter in Caco-2 cells [49] . Other regulatory nuclear factors, such as Sp1, and upstream stimulatory factors are involved in the transcriptional regulation of the carcinoembryonic antigen gene in differentiating Caco-2 cells [48] . The up-regulation of H-ferritin gene transcription in differentiating Caco-2 cells is accompanied by a modification in the activity of the transcription B-box binding factor [47] . Sequence comparison of the VPAC1 receptor promoter with promoters of these genes revealed very low similarity. In particular no consensus regulatory element sequence for the Cdx2 factor was found in the VPAC1 receptor promoter suggesting that regulation of the expression of the receptor during the enterocytic differentiation process involved other nuclear factor(s). This is in line with the fact that in contrast to sucrase isomaltase, which is selectively expressed in intestinal epithelium and uses Cdx2 as an intestine-specific transcription factor [45] , the VPAC1 receptor has a widespread distribution in mammalian tissues [4] . Besides the differentiationdependent transcriptional control of the VPAC1 receptor in human colon cancer Caco-2Cl.20 cells, it may be mentioned that glucocorticoid-mediated downregulation of transcription of the rat VPAC1 receptor in lung cells has been described [35] . As mentioned above, no GRE is present in the 5h-flanking region of the human VPAC1 receptor promoter (see Figure 1) . Finally, retinoic acid has been shown to down-regulate VPAC1 receptor mRNA levels in human breast carcinoma cell lines, probably through inhibition of receptor gene transcription, since no change in mRNA stability was observed upon retinoic acid treatment [50] . Since a retinoic acid responsive element is present in the 5h-flanking region of the human VPAC1 receptor promoter (see Figure 1 ), human colon cancer HT-29 cells transfected with the p1424Luc vector were incubated with retinoic acid. No change in reporter luciferase activity was observed (J.-J. Maoret, unpublished work), suggesting that retinoic acid does not control VPAC1 receptor gene transcription in human colon cancer cells, at least in HT-29 cells.
In conclusion, the present study provides a detailed analysis of the basic organization of the human VPAC1 receptor gene promoter, and characterizes the crucial role of the promoter in the transcriptional control of the VPAC1 receptor during enterocytic differentiation of human colon cancer Caco-2Cl.20 cells. Further efforts will be directed towards identifying the role of the VPAC1 receptor promoter in the regulation of human VPAC1 receptor expression in tumour biology and development.
